JP2008544979A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008544979A5 JP2008544979A5 JP2008518998A JP2008518998A JP2008544979A5 JP 2008544979 A5 JP2008544979 A5 JP 2008544979A5 JP 2008518998 A JP2008518998 A JP 2008518998A JP 2008518998 A JP2008518998 A JP 2008518998A JP 2008544979 A5 JP2008544979 A5 JP 2008544979A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- oxazepan
- oxazolidine
- phenyl
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 11
- -1 oxazepan-4-yl-phenyl Chemical group 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 8
- 208000035143 Bacterial infection Diseases 0.000 claims 5
- 208000022362 bacterial infectious disease Diseases 0.000 claims 5
- 241000894006 Bacteria Species 0.000 claims 3
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 241000588621 Moraxella Species 0.000 claims 2
- 241000186367 Mycobacterium avium Species 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- FOCOZKMFTFOPCZ-UHFFFAOYSA-N 1,3-oxazolidine-5-carboxamide Chemical compound NC(=O)C1CNCO1 FOCOZKMFTFOPCZ-UHFFFAOYSA-N 0.000 claims 1
- 241000606125 Bacteroides Species 0.000 claims 1
- 241000606161 Chlamydia Species 0.000 claims 1
- 241001112695 Clostridiales Species 0.000 claims 1
- 208000008960 Diabetic foot Diseases 0.000 claims 1
- 206010014666 Endocarditis bacterial Diseases 0.000 claims 1
- 241000194033 Enterococcus Species 0.000 claims 1
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 208000001860 Eye Infections Diseases 0.000 claims 1
- 241000192125 Firmicutes Species 0.000 claims 1
- 241000606790 Haemophilus Species 0.000 claims 1
- 241000606768 Haemophilus influenzae Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 241000588655 Moraxella catarrhalis Species 0.000 claims 1
- OIBLANUWJYFXGT-UHFFFAOYSA-N N-methyl-1,3-oxazolidine-5-carboxamide Chemical compound CNC(=O)C1CNCO1 OIBLANUWJYFXGT-UHFFFAOYSA-N 0.000 claims 1
- 206010031252 Osteomyelitis Diseases 0.000 claims 1
- 208000005141 Otitis Diseases 0.000 claims 1
- 206010057190 Respiratory tract infections Diseases 0.000 claims 1
- 241000295644 Staphylococcaceae Species 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000191967 Staphylococcus aureus Species 0.000 claims 1
- 241000191963 Staphylococcus epidermidis Species 0.000 claims 1
- 241000194017 Streptococcus Species 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 241000193996 Streptococcus pyogenes Species 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 208000009361 bacterial endocarditis Diseases 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000019258 ear infection Diseases 0.000 claims 1
- 206010014665 endocarditis Diseases 0.000 claims 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 1
- 208000011323 eye infectious disease Diseases 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 201000007119 infective endocarditis Diseases 0.000 claims 1
- 230000003902 lesion Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 150000003852 triazoles Chemical group 0.000 claims 1
- 0 Cc1c(*)c(N(CC(*)O2)C2=O)cc(*)c1N1C(CC2)[C@@]2CO[C@@]2C1C2 Chemical compound Cc1c(*)c(N(CC(*)O2)C2=O)cc(*)c1N1C(CC2)[C@@]2CO[C@@]2C1C2 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69486205P | 2005-06-29 | 2005-06-29 | |
| PCT/IB2006/001730 WO2007000644A1 (en) | 2005-06-29 | 2006-06-20 | Homomorpholine oxazolidinones as antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008544979A JP2008544979A (ja) | 2008-12-11 |
| JP2008544979A5 true JP2008544979A5 (enExample) | 2009-07-30 |
Family
ID=37101665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008518998A Withdrawn JP2008544979A (ja) | 2005-06-29 | 2006-06-20 | 抗菌剤としてのホモモルホリンオキサゾリジノン |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1899331B1 (enExample) |
| JP (1) | JP2008544979A (enExample) |
| AT (1) | ATE449773T1 (enExample) |
| CA (1) | CA2610978A1 (enExample) |
| DE (1) | DE602006010702D1 (enExample) |
| DK (1) | DK1899331T3 (enExample) |
| ES (1) | ES2335307T3 (enExample) |
| WO (1) | WO2007000644A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8148362B2 (en) | 2006-03-31 | 2012-04-03 | Research Foundation Itsuu Laboratory | Compound having heterocyclic ring |
| JP5455906B2 (ja) * | 2007-08-06 | 2014-03-26 | ミクウルク ファーマシューティカルズ，インコーポレイテッド | 細菌感染症治療のための抗微生物性オルト−フルオロフェニルオキサゾリジノン |
| WO2009044777A1 (ja) | 2007-10-02 | 2009-04-09 | Research Foundation Itsuu Laboratory | ７員ヘテロ環を有するオキサゾリジノン誘導体 |
| WO2015127316A1 (en) | 2014-02-21 | 2015-08-27 | Micurx Pharmaceuticals, Inc. | Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration |
| EA037643B1 (ru) | 2015-07-17 | 2021-04-26 | Зе Глобал Эллайенс Фо Тб Драг Девелопмент, Инк. | Замещенные фенилоксазолидиноны для антимикробной терапии |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK283420B6 (sk) | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| ATE233766T1 (de) | 1994-11-15 | 2003-03-15 | Upjohn Co | Antibakterielle bizyklische oxazin und thiazin- oxazolidinone |
| AU739055B2 (en) | 1997-11-12 | 2001-10-04 | Pharmacia & Upjohn Company | Oxazolidinone derivatives and pharmaceutical compositions |
| JP2000204084A (ja) | 1998-11-11 | 2000-07-25 | Hokuriku Seiyaku Co Ltd | チオカルバミド酸誘導体 |
| JP2002531455A (ja) | 1998-11-27 | 2002-09-24 | ファルマシア・アンド・アップジョン・カンパニー | チオカルボニル官能基を有するオキサゾリジノン抗細菌剤 |
| US6297242B1 (en) | 1999-08-12 | 2001-10-02 | Ortho-Mcneil Pharmaceutical, Inc. | N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof |
| EP1242417A1 (en) | 1999-12-21 | 2002-09-25 | PHARMACIA & UPJOHN COMPANY | Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| AU2001253113B2 (en) | 2000-04-20 | 2005-02-03 | Pharmacia & Upjohn Company | Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis |
| ES2245698T3 (es) | 2000-06-30 | 2006-01-16 | PHARMACIA & UPJOHN COMPANY LLC | Composiciones para el tratamiento de infecciones bacterianas que contienen un compuesto de oxazolidinona, sulbactam y ampicilina. |
| GB0017225D0 (en) | 2000-07-14 | 2000-08-30 | Really Useful Products Limited | Container |
| CZ2003228A3 (cs) | 2000-07-17 | 2003-06-18 | Ranbaxy Laboratories Limited | Oxazolidinonové deriváty jako antimikrobiální látky |
| DE10034627A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Aryl-substituierte Oxazolidinone mit Cytokin inhibitorischer Wirkung |
| WO2003008389A1 (en) | 2001-07-16 | 2003-01-30 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as potential antimicrobials |
| EP1311870B1 (en) | 2000-08-24 | 2011-04-27 | SiRF Technology, Inc. | Apparatus for reducing auto-correlation or cross-correlation in weak cdma signals |
| AR031135A1 (es) | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| MXPA03006958A (es) | 2001-02-05 | 2003-11-18 | Upjohn Co | Composicion para administracion rectal de farmaco antibacterial de oxazolidinona. |
| DE10105989A1 (de) | 2001-02-09 | 2002-08-14 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| GB0108793D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
| WO2002081470A1 (en) | 2001-04-07 | 2002-10-17 | Astrazeneca Ab | Oxazolidinones containing a sulfonimid group as antibiotics |
| US6956040B2 (en) | 2001-07-16 | 2005-10-18 | Ranbaxy Laboratories Limited | Oxazolidinone piperazinyl derivatives as potential antimicrobials |
| TW200302095A (en) | 2002-01-25 | 2003-08-01 | Upjohn Co | Oxazolidinone cotherapy |
| CA2477044A1 (en) | 2002-02-22 | 2003-09-04 | Pharmacia Corporation | Ophthalmic formulation with gum system |
| AU2003218059A1 (en) | 2002-02-22 | 2003-09-09 | Pharmacia Corporation | Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride |
| AR038536A1 (es) | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
| RU2004129278A (ru) | 2002-02-28 | 2005-06-10 | Астразенека Аб (Se) | Химические соединения |
| US7473699B2 (en) | 2002-02-28 | 2009-01-06 | Astrazeneca Ab | 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents |
| CA2476545A1 (en) | 2002-03-29 | 2003-10-16 | Pharmacia & Upjohn Company | Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
| AU2003224345A1 (en) | 2002-04-30 | 2003-11-17 | Orchid Chemicals & Pharmaceuticals | Antibacterial agents |
| TW200403240A (en) | 2002-06-28 | 2004-03-01 | Upjohn Co | Difluorothioacetamides of oxazolidinones as antibacterial agents |
| WO2004009587A1 (en) | 2002-07-22 | 2004-01-29 | Orchid Chemicals & Pharmaceuticals Ltd | Oxazolidinone derivatives as antibacterial agents |
| AU2002319848A1 (en) | 2002-07-29 | 2004-02-25 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
| AU2003253141A1 (en) | 2002-08-22 | 2004-03-11 | Orchid Chemicals And Pharmaceuticals Ltd | Novel antibacterial agents |
-
2006
- 2006-06-20 AT AT06779767T patent/ATE449773T1/de not_active IP Right Cessation
- 2006-06-20 EP EP06779767A patent/EP1899331B1/en not_active Not-in-force
- 2006-06-20 ES ES06779767T patent/ES2335307T3/es active Active
- 2006-06-20 JP JP2008518998A patent/JP2008544979A/ja not_active Withdrawn
- 2006-06-20 DK DK06779767.0T patent/DK1899331T3/da active
- 2006-06-20 CA CA002610978A patent/CA2610978A1/en not_active Abandoned
- 2006-06-20 WO PCT/IB2006/001730 patent/WO2007000644A1/en not_active Ceased
- 2006-06-20 DE DE602006010702T patent/DE602006010702D1/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009526832A5 (enExample) | ||
| KR100340365B1 (ko) | 옥사졸리디논유도체및이들을함유하는약학조성물 | |
| AU782078B2 (en) | Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents | |
| AU2014208965B2 (en) | Compounds and methods for treating bacterial infections | |
| US20010047004A1 (en) | Oxazolidinone thioamides with piperazine amide substituents | |
| JP4607107B2 (ja) | シクロプロピル基置換されたオキサゾリジノン抗生物質およびこれらの誘導体 | |
| US20100286211A1 (en) | Oxazolidinone derivatives as antimicrobials | |
| JP2000505084A (ja) | アゾリルピペラジニルフェニルオキサゾリジノン抗微生物剤 | |
| AU739055B2 (en) | Oxazolidinone derivatives and pharmaceutical compositions | |
| CA2489128A1 (en) | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections | |
| JP2004525876A (ja) | 抗細菌活性を有する新規複素環式化合物、それらの調製方法、およびそれらを含有する薬学的組成物 | |
| EP3500567A1 (en) | Antibiotic compounds | |
| WO2008143649A2 (en) | Novel oxazolidinone compounds as antiinfective agents | |
| US6686363B2 (en) | Cyclopropyl containing oxazolidinone antibiotics and derivatives thereof | |
| US6642238B2 (en) | Oxazolidinone thioamides with piperazine amide substituents | |
| JP2008544979A5 (enExample) | ||
| JP2009525318A5 (enExample) | ||
| JP2008534672A5 (enExample) | ||
| JP2009526036A5 (enExample) | ||
| JP2009503021A5 (enExample) | ||
| JP2008544979A (ja) | 抗菌剤としてのホモモルホリンオキサゾリジノン | |
| JP2008546825A5 (enExample) | ||
| AU2002362028B2 (en) | Cyclopropyl hexane containing oxazolidinone antibiotics and derivatives thereof | |
| CA2243706C (en) | Azolyl piperazinyl phenyl oxazolidinone antimicrobials | |
| WO2006018682A2 (en) | Oxazolidinone derivatives as antimicrobials |